NanOlogy enrols first patient in phase 2 trial of NanoPac for intratumoral treatment of prostate cancer

NanOlogy enrols first patient in phase 2 trial of NanoPac for intratumoral treatment of prostate cancer. (Credit: Philippe Delavie from Pixabay)